Congratulations to all members of the Department who have recently been awarded research grants. Here is our round-up of the latest funding successes.
Please note, this list comprises awards that have recently been set up on College’s grants management system, with some manual additions. It may not, therefore, include all new grants awarded to Principal Investigators in the Department.
| Project Lead | Co-Investigator(s) | Funder | Combined Scheme | Project Title | Amount |
| Goedele Maertens | MRC Medical Research Council (MRC) | Infections and immunity research | Linking the HTLV-1 pre-integration complex to the chromatin | £983,600 | |
| Andrew Edwards | Gerald Larrouy-Maumus | BBSRC Biotechnology and Biological Sciences Research Council | Responsive mode research grants | PA7700 Determining how polymyxins kill bacteria | £616,800 |
| Darius Armstrong-James | Wendy Barclay, Cecilia Johansson | MRC Medical Research Council (MRC) | Tackling Emerging Co-Infections | Comparative analysis of post-viral fungal pneumonia in influenza and SARS-Cov2 infected rodents | £24,000 |
| Robin Shattock | John Tregoning, Nilay Shah, Karen Polizzi, Cleo Kontoravdi, Maria Papathanasiou, Rongjun Chen, Talia Shmool, Jason Hallett, Molly Stevens, David Peeler | EPSRC Engineering & Physical Sciences Research Council | Vaccines Manufacturing Research Hubs | Future vaccine manufacturing hub : Accelerating the manufacture and deployment of cost effective vaccines (DHSC) | £10,500,000 |
| Alan Winston-O’keefe | Jasmini Alagaratnam | Gilead Sciences Inc | Gilead’s Research Scholars Program in HIV: Early career investigators in the Europe, Canada and Australia | Associations between plasma biomarkers and longitudinal changes in cognitive function: The POPPY study | £100,000 |
| James Seddon | European and Developing Countries Clinical Trial Partnership | Research and Innovation actions supporting the global health EDCTP3 Joint Undertaking | Validation of treatment decision algorithms | €5,400,000 | |
| Tom Parks | Evangelos Bellos | US Centres for Disease Control and Prevention | Vanderbilt University Medical Center Default Scheme | PA3676: Host genetic susceptibility to group A streptococcal necrotising fasciitis and toxic shock syndrome | £57,612 |
| Tom Parks | Shiranee Sriskandan, Myrsini Kaforou ,Michael Levin | Leducq Foundation | 2021-2022 ARF BIOMARKER PROJECT | PA2266: Acute Rheumatic Fever Diagnostic Collaborative (ARC) Network | £396,348 |